Fecal microbiota transplant    (DrugBank: -)

2 diseases
IDDisease name (Link within this page)Number of trials
96Crohn disease12
97Ulcerative colitis31

96. Crohn disease    [ 2,209 clinical trials,   1,276 drugs,   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways]
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
12 / 2,209 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03747718
(ClinicalTrials.gov)
December 1, 20208/3/2018Randomized Trial Comparing Single vs. Maintenance Fecal Microbiota Transplant for Refractory Crohn's Disease in ChildrenA Study for Evaluation of Clinical Response to Single vs. Maintenance Fecal Microbiota Transplantation in Pediatric Patients With Refractory Crohn's DiseaseCrohn DiseaseBiological: Fecal Microbiota Transplantation;Other: PlaceboStanford UniversityNULLNot yet recruiting2 Years25 YearsAll30Phase 1United States
2EUCTR2019-003816-29-FR
(EUCTR)
16/12/201914/10/2019Fecal microbiota transplantation in Crohn’s disease as relay after anti-TNF withdrawalFecal microbiota transplantation in Crohn’s disease as relay after anti-TNF withdrawal - MIRACLE Adult patients with Crohn’s disease diagnosed for at least 6 months and healthy volunteers donors
MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;System Organ Class: 10017947 - Gastrointestinal disorders ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
ASSISTANCE PUBLIQUE -HOPITAUX DE PARIS (AP-HP)NULLAuthorised-recruitment may be ongoing or finished Female: yes
Male: yes
200Phase 3France
3NCT03378167
(ClinicalTrials.gov)
December 1, 201812/12/2017PediCRaFT: Pediatric Crohn's Disease Fecal Transplant TrialPediCRaFT: Pediatric Crohn's Disease Fecal Microbiota Transplant Pilot StudyCrohn Disease;Pediatric Crohns Disease;Inflammatory Bowel Diseases;ColitisBiological: MICROBIOTA;Biological: PLACEBOMcMaster Children's HospitalHamilton Health Sciences Corporation;McMaster UniversityRecruiting3 Years17 YearsAll45Phase 1Canada
4NCT02330211
(ClinicalTrials.gov)
July 17, 201729/12/2014Fecal Microbiota Transplant (FMT) in Pediatric Active Crohn's ColitisA Phase I/II, Double Blinded, Placebo Controlled, Single-center Study of Fecal Microbiota Transplant (FMT) for the Treatment of Active Pediatric Crohn's ColitisInflammatory Bowel Diseases;Crohn DiseaseBiological: Fecal Microbiota Transplant;Biological: PlaceboStacy A. KahnNULLCompleted5 Years30 YearsAll4Phase 1;Phase 2United States
5NCT03078803
(ClinicalTrials.gov)
March 28, 201712/1/2017Fecal Transplant for Crohn's DiseaseA Prospective Multicenter Randomized Controlled Trial Comparing Fecal Microbiota Transplantation (FMT) to Placebo in the Treatment of Mild to Moderate Crohn's DiseaseCrohn DiseaseBiological: Fecal Microbiota Transplant (FMT);Biological: PlaceboUniversity of AlbertaUniversity of Calgary;McMaster UniversityRecruiting18 YearsN/AAll126Phase 2Canada
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
6NCT02636517
(ClinicalTrials.gov)
December 201516/12/2015Fecal Microbiome TransplantFecal Microbiome Transplant in Pediatric C. DifficileClostridium Difficile;Inflammatory Bowel Disease;Crohn's Disease;Ulcerative ColitisBiological: Fecal Microbiota TransplantChildren's Hospital of PhiladelphiaNULLActive, not recruiting3 Years21 YearsAll50N/AUnited States
7NCT02330653
(ClinicalTrials.gov)
November 201529/12/2014Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's ColitisA Phase I/II, Double Blinded, Placebo Controlled, Single-center Study of Fecal Microbiota Transplant (FMT) for the Treatment of Active Pediatric Ulcerative Colitis and Pediatric Active Crohn's ColitisInflammatory Bowel Diseases;Ulcerative Colitis;Crohn DiseaseBiological: Fecal Microbiota Transplant (FMT);Biological: PlaceboStacy A. KahnNULLCompleted5 Years30 YearsAll15Phase 1;Phase 2United States
8NCT02417974
(ClinicalTrials.gov)
September 20151/4/2015Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)Crohn's DiseaseBiological: Fecal Microbiota Transplant (FMT)Boston Medical CenterBrigham and Women's Hospital;Beth Israel Deaconess Medical Center;Massachusetts Institute of TechnologySuspended18 YearsN/AAll44Phase 2United States
9NCT02575040
(ClinicalTrials.gov)
May 20156/10/2015Efficacy of Fecal Microbiota Transplantation for Inflammatory Bowel DiseaseEfficacy of Fecal Microbiota Transplantation for Refractory Inflammatory Bowel DiseaseUlcerative Colitis;Crohn Disease;Constipation (Excl Faecal Impaction)Biological: Fecal microbiota transplantationGulhane Military Medical AcademyNULLRecruiting18 YearsN/ABoth60Phase 3Turkey
10NCT02335281
(ClinicalTrials.gov)
January 20157/1/2015Standardized Fecal Microbiota Transplantation for Inflammatory Bowel DiseaseEfficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation for Severe Inflammatory Bowel DiseaseInflammatory Bowel Disease;Ulcerative Colitis;Crohn's DiseaseProcedure: FMT;Drug: MesalazineYanling WeiNULLRecruiting16 Years70 YearsBoth40Phase 2China
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
11NCT02108821
(ClinicalTrials.gov)
September 201421/3/2014Fecal Microbiota Transplantation in Pediatric PatientsA Study of Fecal Microbiota Transplantation in Pediatric Patients With Relapsed Inflammatory Bowel Disease.Inflammatory Bowel Diseases (IBD);Crohn's Disease (CD);Ulcerative Colitis (UC)Biological: Fecal Microbiota Transplantation (FMT)Children's Mercy Hospital Kansas CityUniversity of PittsburghCompleted2 Years22 YearsAll23Phase 1United States
12NCT02199561
(ClinicalTrials.gov)
July 201422/7/2014Fecal Microbiota Transplantation (FMT) in the Management of Active Crohn's DiseaseA Prospective, Single Center, Open Label Trial of Fecal Microbiota Transplantation (FMT) in the Management of Active Crohn's DiseaseCrohn's DiseaseBiological: Fecal Microbiota TransplantUniversity of AlbertaNULLCompleted18 Years65 YearsBoth3Phase 1;Phase 2Canada

97. Ulcerative colitis    [ 2,269 clinical trials,   1,331 drugs,   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways]
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
31 / 2,269 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04521205
(ClinicalTrials.gov)
September 202018/8/2020A Multicenter Clinical Trial: Efficacy, Safety of Fecal Microbiota Transplantation for Inflammatory Bowel DiseaseA Multicenter Clinical Trial: Efficacy, Safety of Fecal Microbiota Transplantation for Inflammatory Bowel DiseaseInflammatory Bowel Disease, Ulcerative Colitis TypeDrug: fecal microbiota capsuleZhongshan Hospital Xiamen UniversityNULLRecruiting18 Years65 YearsAll200Phase 1China
2NCT04373473
(ClinicalTrials.gov)
July 15, 202028/4/2020Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative ColitisA Phase 2a, Randomized, Double-blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation (PRIM-DJ2727) Administered Orally in Combination With Standard of Care Therapy for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative ColitisAdults With Ulcerative ColitisDrug: PRIM-DJ2727;Drug: PlacebosThe University of Texas Health Science Center, HoustonNULLNot yet recruiting18 YearsN/AAll58Phase 2NULL
3NCT04231110
(ClinicalTrials.gov)
July 1, 20202/1/2020Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Ulcerative ColitisCombination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Ulcerative ColitisUlcerative ColitisBiological: Fecal microbiota transplantationMcMaster UniversityNULLNot yet recruiting18 YearsN/AAll10Phase 4NULL
4NCT04202211
(ClinicalTrials.gov)
February 202013/12/2019FMT for Remission of Active Ulcerative Colitis in AdultsA Randomized Double-blind, Placebo-controlled Trial of Lyophilized Fecal Microbiota Transplantation for the Induction of Remission in Adults With Active Ulcerative ColitisUlcerative Colitis;Inflammatory Bowel DiseasesBiological: FMT oral;Biological: FMT enema;Other: Placebo oral;Other: Placebo enemaUniversity of British ColumbiaCrohn's and Colitis Canada;Vancouver Island Health AuthorityNot yet recruiting18 YearsN/AAll145Phase 2Canada
5NCT03998488
(ClinicalTrials.gov)
January 31, 202024/6/2019Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative ColitisA Randomized, Placebo-controlled Clinical Trial Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Subsequent Dietary Fiber in Patients With Moderate Ulcerative ColitisUlcerative Colitis;Inflammatory Bowel DiseasesDrug: Fecal Microbiota Transplantation;Dietary Supplement: Psyllium Husk PowderWeill Medical College of Cornell UniversityCrohn's and Colitis FoundationRecruiting18 Years89 YearsAll135Phase 2United States
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
6NCT03483246
(ClinicalTrials.gov)
June 18, 201926/2/2018Impact of Fecal Microbiota Transplantation in Ulcerative ColitisImpact of Fecal Microbiota Transplantation in Ulcerative Colitis: a Randomized, Sham Controlled TrialUlcerative ColitisDrug: Fecal Microbiota Transplantation (FMT);Drug: Sham-transplantation PlaceboAssistance Publique - Hôpitaux de ParisCRB-HUEP;Institut National de la Santé Et de la Recherche Médicale, FranceRecruiting18 Years75 YearsAll150Phase 3France
7NCT03804931
(ClinicalTrials.gov)
January 20, 20196/1/2019Fecal Microbiota Transplantation for Ulcerative ColitisEfficacy and Safety of Fecal Microbiota Transplantation for Ulcerative ColitisUlcerative Colitis;Fecal Microbiota TransplantationProcedure: Fecal microbiota transplantation;Procedure: Infusion of Saline;Drug: 5-Aminosalicylic acid(5-ASA) and/or PrednisoneGuangzhou First People's HospitalNULLRecruiting18 Years65 YearsAll120Phase 2;Phase 3China
8NCT03716388
(ClinicalTrials.gov)
December 1, 201821/10/2018Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UCFecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC : a Pilot StudyUlcerative Colitis Chronic Mild;Ulcerative Colitis Chronic ModerateBiological: Fecal Microbiota Transplantation;Drug: Mesalamine Granules;Other: Placebo infusion;Other: Placebo granulesDayanand Medical College and HospitalColitis & Crohn's Foundation (India)Recruiting18 Years75 YearsAll20Phase 3India
9EUCTR2017-004967-11-FR
(EUCTR)
26/06/201806/04/2018Prospective multicenter randomized controlled double-blind label study of the prophylaxis of recurrent pouchitis after fecal microbiota transplant in UC with ileo-anal anastomosis.Poca - Poca Patients operated with an IPAA for Ulcerative Colitis with active recurrent pouchitis, who respond after 4 weeks of an antibiotherapy, will be randomized
MedDRA version: 20.1;Level: LLT;Classification code 10000638;Term: Active ileal inflammation;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: suspension de microbiote fécal
Product Code: PRD5973697
CHU NantesNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
42Phase 3France
10NCT03378921
(ClinicalTrials.gov)
February 27, 201811/12/2017Fecal Microbiota Transplantation in the Treatment of PouchitisDouble-blinded Randomized Placebo Controlled Study: Fecal Microbiota Transplantation in the Treatment of Chronic PouchitisPouchitis;Ulcerative ColitisBiological: Fecal microbiota transplantation;Biological: PlaceboHelsinki University Central HospitalNULLCompleted18 Years75 YearsAll26Phase 2Finland
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
11NCT03006809
(ClinicalTrials.gov)
March 2, 201721/12/2016Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative ColitisOptimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative ColitisUlcerative ColitisBiological: Fecal Microbiota Transplantation (FMT), OpenBiome;Other: pretreatment antibioticsNajwa ElnachefNULLRecruiting18 Years64 YearsAll40Phase 1United States
12NCT02998112
(ClinicalTrials.gov)
December 201613/12/2016Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral TubingUlcerative ColitisDrug: fecal microbiota transplantation;Drug: SalineThe Second Hospital of Nanjing Medical UniversityFourth Military Medical University;First Hospital of Guangzhou;Daping Hospital and the Research Institute of Surgery of the Third Military Medical University;Zhongshan Hospital Xiamen UniversityRecruiting18 Years65 YearsBoth188Phase 4China
13NCT02516384
(ClinicalTrials.gov)
October 1, 201629/7/2015Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)Ulcerative ColitisBiological: Fecal Microbiota TransplantationWeill Medical College of Cornell UniversityNULLCompleted18 YearsN/AAll20Phase 1United States
14JPRN-UMIN000026485
2016/08/0110/03/2017Research on the Efficacy of Fecal Microbiota Transplantation and Microbiota in Japanese Children with Ulcerative Colitis. ulcerative colitisFecal Microbiota Transplantation(on Day1, 2 and 3, week 2, 3 and 5) after antibiotic pretreatment using amoxicillin 40mg/kg/day, fosfomycin 100mg/kg/day and metronidazole 16mg/kg/day.National Center for Child Health and Development10Probiotics Research Laboratory, Juntendo University Graduate School of Medicine, Tokyo, Japan. Yakult Central Institute, Tokyo, JapanRecruiting2years-old18years-oldMale and Female12Not selectedJapan
15NCT02390726
(ClinicalTrials.gov)
December 201519/2/2015Fecal Microbiota Transplant in the Treatment of Ulcerative ColitisFecal Microbiota Transplant in the Treatment of Ulcerative ColitisUlcerative Colitis, Active ModerateBiological: Fecal Microbiota Transplant;Biological: PlaceboUniversity of VermontNULLUnknown status18 Years75 YearsAll20Early Phase 1United States
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
16NCT02636517
(ClinicalTrials.gov)
December 201516/12/2015Fecal Microbiome TransplantFecal Microbiome Transplant in Pediatric C. DifficileClostridium Difficile;Inflammatory Bowel Disease;Crohn's Disease;Ulcerative ColitisBiological: Fecal Microbiota TransplantChildren's Hospital of PhiladelphiaNULLActive, not recruiting3 Years21 YearsAll50N/AUnited States
17NCT02330653
(ClinicalTrials.gov)
November 201529/12/2014Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's ColitisA Phase I/II, Double Blinded, Placebo Controlled, Single-center Study of Fecal Microbiota Transplant (FMT) for the Treatment of Active Pediatric Ulcerative Colitis and Pediatric Active Crohn's ColitisInflammatory Bowel Diseases;Ulcerative Colitis;Crohn DiseaseBiological: Fecal Microbiota Transplant (FMT);Biological: PlaceboStacy A. KahnNULLCompleted5 Years30 YearsAll15Phase 1;Phase 2United States
18NCT02487238
(ClinicalTrials.gov)
November 201525/6/2015Pediatric FEcal Microbiota Transplant for Ulcerative ColitisA Single-Blind, Randomized, Placebo-Controlled Trial of Human Fecal Microbiota Transplantation for the Therapy of Pediatric Ulcerative Colitis and Inflammatory Bowel Disease UnclassifiedInflammatory Bowel Disease;Ulcerative ColitisBiological: Fecal Microbiota Enema;Biological: Normal Saline EnemaMcMaster Children's HospitalLondon Health Sciences Centre;St. Justine's HospitalCompleted3 Years17 YearsAll35Phase 1Canada
19JPRN-UMIN000018642
2015/08/1211/08/2015A trial of fecal microbiota transplantation and / or antibiotics therapy for ulcerative colitis ulcerative colitisAntibiotics therapy:Taking three kinds of antibiotics (Amoxicillin, fosmycin, metronidazole) for two weeks.
FMT:Administration of the fecal material from healthy donors to patients.
Juntendo university school of medicine Department of gastroenterologyNULLRecruiting6years-oldNot applicableMale and Female50Not selectedJapan
20NCT04434872
(ClinicalTrials.gov)
July 201528/5/2015Fecal Microbiota Transplantation as a Treatment for Ulcerative ColitisUlcerative ColitisProcedure: Colonoscopy;Procedure: Gastroscopy;Drug: Fecal Microbiota;Procedure: EnemaTel-Aviv Sourasky Medical CenterNULLTerminated18 Years70 YearsAll80Phase 2Israel
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
21NCT02435160
(ClinicalTrials.gov)
May 201523/4/2015The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative ColitisUlcerative Colitis;Fecal Microbiota TransplantationBiological: Fecal Microbiota TransplantationJun LiuNULLNot yet recruiting25 Years60 YearsMale20Phase 2;Phase 3NULL
22NCT02575040
(ClinicalTrials.gov)
May 20156/10/2015Efficacy of Fecal Microbiota Transplantation for Inflammatory Bowel DiseaseEfficacy of Fecal Microbiota Transplantation for Refractory Inflammatory Bowel DiseaseUlcerative Colitis;Crohn Disease;Constipation (Excl Faecal Impaction)Biological: Fecal microbiota transplantationGulhane Military Medical AcademyNULLRecruiting18 YearsN/ABoth60Phase 3Turkey
23NCT02335281
(ClinicalTrials.gov)
January 20157/1/2015Standardized Fecal Microbiota Transplantation for Inflammatory Bowel DiseaseEfficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation for Severe Inflammatory Bowel DiseaseInflammatory Bowel Disease;Ulcerative Colitis;Crohn's DiseaseProcedure: FMT;Drug: MesalazineYanling WeiNULLRecruiting16 Years70 YearsBoth40Phase 2China
24NCT02108821
(ClinicalTrials.gov)
September 201421/3/2014Fecal Microbiota Transplantation in Pediatric PatientsA Study of Fecal Microbiota Transplantation in Pediatric Patients With Relapsed Inflammatory Bowel Disease.Inflammatory Bowel Diseases (IBD);Crohn's Disease (CD);Ulcerative Colitis (UC)Biological: Fecal Microbiota Transplantation (FMT)Children's Mercy Hospital Kansas CityUniversity of PittsburghCompleted2 Years22 YearsAll23Phase 1United States
25NCT02227342
(ClinicalTrials.gov)
July 201422/7/2014Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative ColitisA Prospective, Single Center, Open Label Trial of Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative ColitisUlcerative ColitisBiological: Fecal Microbiota TransplantUniversity of AlbertaNULLCompleted18 Years65 YearsBoth3Phase 1;Phase 2Canada
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
26NCT02049502
(ClinicalTrials.gov)
July 201427/1/2014FMT in Ulcerative Colitis-Associated PouchitisThe Use of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis-associated PouchitisUlcerative Colitis Associated PouchitisBiological: biologically active human fecal microbiota;Procedure: sigmoidoscopyVirginia O. ShafferNULLCompleted18 Years65 YearsAll8Phase 2United States
27JPRN-UMIN000014152
2014/06/0404/06/2014A trial of a combination therapy of fecal microbiota transplantation and antibiotics or simple fecal microbiota therapy for ulcerative colitis ulcerative colitisAdministration of the fecal material from healthy donors to patients after taking three kinds of antibiotics (Amoxicillin, fosmycin, metronidazole) for two weeksJuntendo university school of medicine Department of gastroenterologyNULLRecruiting20years-oldNot applicableMale and Female30Not selectedJapan
28NCT01947101
(ClinicalTrials.gov)
February 201413/9/2013Fecal Microbiota Transplantation (FMT) for Treatment of Ulcerative Colitis in ChildrenA Phase I Study of Fecal Microbiota Transplantation (FMT) in Immunomodulator Dependent Pediatric Ulcerative Colitis (UC)Ulcerative ColitisBiological: Fecal Microbiota TransplantBaylor College of MedicineNULLCompleted12 Years20 YearsBoth6Phase 1United States
29NCT02033408
(ClinicalTrials.gov)
January 20143/12/2013Manipulating the Microbiome in IBD by Antibiotics and FMTManipulating the Microbiome in IBD by Antibiotics and Fecal Microbiota Transplantation (FMT): a Randomized Controlled TrialExacerbation of Ulcerative Colitis;Ulcerative Colitis, Active Severe;Crohn's ColitisDrug: AB (antibiotics);Drug: CS (corticosteroids) OnlyShaare Zedek Medical CenterNULLActive, not recruiting2 Years75 YearsAll28Phase 4Canada;Finland;Israel;Italy;Poland;Spain
30NCT02058524
(ClinicalTrials.gov)
June 201327/8/2013A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative ColitisA Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative ColitisUlcerative ColitisBiological: fecal microbiota transplantationUniversity of ChicagoNULLTerminated18 Years65 YearsBoth1Phase 1United States
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
31NCT01790061
(ClinicalTrials.gov)
November 20129/2/2013Standardized Fecal Microbiota Transplantation for Ulcerative ColitisEfficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation in Patients With Moderate to Severe Ulcerative ColitisBacteria;Microbiota;Fecal Microbiota Transplantation;Inflammatory Bowel Disease;Ulcerative ColitisProcedure: Standardized FMT;Drug: Traditional treatmentsThe Second Hospital of Nanjing Medical UniversityAir Force Military Medical University, ChinaRecruiting6 Years80 YearsAll500Phase 2;Phase 3China